ArticleInternational journal of pharmaceutics: X2026

Quality by design-based development of ibrutinib polymer-lipid hybrid nanoparticles for enhanced lymphatic absorption and anticancer efficacy.

Pragathi Devanand Bangera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.